Reduction in rate of node metastases with breast screening: consistency of association with tumor size I. D. NagtegaalS. W. Duffy Review 23 December 2012 Pages: 653 - 663
A systematic review of elastography, electrical impedance scanning, and digital infrared thermography for breast cancer screening and diagnosis Thomas D. VreugdenburgCameron D. WillisJanet E. Hiller Review 04 January 2013 Pages: 665 - 676
Expression of melatonin receptors in triple negative breast cancer (TNBC) in African American and Caucasian women: relation to survival Gabriela Oprea-IliesErhard HausCynthia Cohen Preclinical Study Open access 19 December 2012 Pages: 677 - 687
14-3-3ζ as a predictor of early time to recurrence and distant metastasis in hormone receptor-positive and -negative breast cancers Anna BergamaschiJonna FrasorBenita S. Katzenellenbogen Preclinical study 28 December 2012 Pages: 689 - 696
2-Hydroxycinnamaldehyde inhibits the epithelial-mesenchymal transition in breast cancer cells Ismail Ahmed IsmailHye Sook KangByoung-Mog Kwon Preclinical Study 03 January 2013 Pages: 697 - 708
Elevated expression of podocalyxin is associated with lymphatic invasion, basal-like phenotype, and clinical outcome in axillary lymph node-negative breast cancer Catherine L. ForseYildiz E. YilmazIrene L. Andrulis Preclinical Study 04 January 2013 Pages: 709 - 719
Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients Sameer MirzaEmad A. RakhaVimla Band Preclinical study Open access 04 January 2013 Pages: 721 - 731
Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages Ahmed A. AlkhateebBing HanJames R. Connor Preclinical Study 11 January 2013 Pages: 733 - 744
Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer E. BurandtG. JensA. Lebeau Preclinical study 16 January 2013 Pages: 745 - 753
A randomized and open-label trial evaluating the addition of pazopanib to lapatinib as first-line therapy in patients with HER2-positive advanced breast cancer Stephen R. D. JohnstonHenry GómezDennis Slamon Clinical Trial 03 January 2013 Pages: 755 - 766
Adjuvant chemotherapy reduces the incidence of abdominal hypertrophic scarring following immediate TRAM breast reconstruction Taik Jong LeeWoo Shik JeongEun Key Kim Clinical Trial 03 January 2013 Pages: 767 - 771
High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival Akimitsu YamadaTakashi IshikawaItaru Endo Clinical Trial 04 January 2013 Pages: 773 - 782
Which nomogram is best for predicting non-sentinel lymph node metastasis in breast cancer patients? A meta-analysis Liling ZhuLiang JinFengxi Su Clinical Trial 05 January 2013 Pages: 783 - 795
Can additional immunohistochemistry staining replace the surgical excision for the diagnosis of papillary breast lesions classified as benign on 14-gage core needle biopsy? Ja Seung KooKyunghwa HanByeong-Woo Park Clinical Trial 06 January 2013 Pages: 797 - 806
Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes Guofang HouSheng ZhangJin Zhang Clinical Trial 06 January 2013 Pages: 807 - 816
Interpersonal influences and attitudes about adjuvant therapy treatment decisions among non-metastatic breast cancer patients: an examination of differences by age and race/ethnicity in the BQUAL study Rachel C. SheltonGrace Clarke HillyerAlfred I. Neugut Epidemiology 22 December 2012 Pages: 817 - 828
Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider–patient communication Yihang LiuJennifer L. MalinRose C. Maly Epidemiology 23 December 2012 Pages: 829 - 836
Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer Xiaohong R. YangJonine D. FigueroaMark E. Sherman Epidemiology 28 December 2012 Pages: 837 - 847
Given breast cancer, is fat better than thin? Impact of the estrogen receptor beta gene polymorphisms Signe BorgquistMaria HjertbergHelena Jernström Epidemiology 29 December 2012 Pages: 849 - 862
Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study Henry KaplanJudith MalmgrenAnneclaire J. De Roos Epidemiology 30 December 2012 Pages: 863 - 867
Physical activity and risk of breast cancer: a meta-analysis of prospective studies Yili WuDongfeng ZhangShan Kang Epidemiology 30 December 2012 Pages: 869 - 882
Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up Xuehong ZhangShelley S. TworogerSusan E. Hankinson Epidemiology 03 January 2013 Pages: 883 - 892
IL-21 gene polymorphism is associated with the prognosis of breast cancer in Chinese populations Yonghe YouJieqiong DengYifeng Zhou Epidemiology 04 January 2013 Pages: 893 - 901
Supplement use during an intergroup clinical trial for breast cancer (S0221) Gary R. ZirpoliPatrick M. BrennanChristine B. Ambrosone Epidemiology Open access 10 January 2013 Pages: 903 - 913
Effects of menopausal hormone therapy on ductal carcinoma in situ of the breast Juhua LuoBarbara B. CochraneKaren L. Margolis Epidemiology 12 January 2013 Pages: 915 - 925
CD24 polymorphisms in breast cancer: impact on prognosis and risk Katharina BuckSarah HugFrederik Marmé Epidemiology 13 January 2013 Pages: 927 - 937
